Definitive Agreement
-
Biologics
MiMedx Signs Definitive Agreement to Divest Stability Biologics Subsidiary as Company’s Strategic Focus on Biopharma
MARIETTA, Ga., Aug. 18, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics…
Read More »